Advertisement
Advertisement
U.S. markets close in 4 hours 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Enzon Pharmaceuticals, Inc. (ENZN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4100+0.0200 (+5.13%)
As of 10:03AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3900
Open0.4059
Bid0.3800 x 3000
Ask1.4100 x 200
Day's Range0.4059 - 0.4100
52 Week Range0.2400 - 0.4900
Volume9,060
Avg. Volume48,135
Market Cap30.428M
Beta (5Y Monthly)0.04
PE Ratio (TTM)N/A
EPS (TTM)-0.0380
Earnings DateAug 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 30, 2019
1y Target Est14.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ENZN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ENZON PHARMACEUTICALS INC
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement